Inspection Record
View the regulator's official source The source document is always the basis for judgement.
There is a failure to thoroughly review any unexplained discrepancy, the failure of a batch or any of its components to meet any of its specifications, whether or not the batch has been already distributed.
Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are not established, written, followed, or including adequate validation of the sterilization | process.
Aseptic processing areas are deficient regarding the system for monitoring environmental conditions.
Extracted automatically from the document US FDA published on 2025-12-29. The source is available at the link above.
This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.
Translation and classification are automated and may differ in nuance from the source.
Growth stages previewSolve a quiz to start hatching
Your growth record is stored safely in this browser.
